Cart
sales@molnova.com
Calmodulin-Dependent Protein Kinase II (281 - 289)
CAS No. ———
Calmodulin-Dependent Protein Kinase II (281 - 289)( ——— )
Catalog No. M41235 CAS No. ———
Calmodulin-Dependent Protein Kinase II (281 - 289)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCalmodulin-Dependent Protein Kinase II (281 - 289)
-
NoteResearch use only, not for human use.
-
Brief DescriptionCalmodulin-Dependent Protein Kinase II (281 - 289)
-
DescriptionCalmodulin-Dependent Protein Kinase II (281 - 289)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1118.26
-
Molecular FormulaC43H71N15O16S2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
HA15
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
-
pTH (1-84) (human)
pTH (1-84) (human)
-
PF-3758309 hydrochlo...
PF-3758309, also known as PF-03758309, is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity.
